News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Startup Ozette unveils AI approach to understanding the immune system
Seattle-based startup Ozette raised $6 million in seed funding to propel its new AI-driven immune technology. While the company’s main focus is on accelerating analysis
Jeff Bezos-backed startup Nautilus Biotechnology set to go public via SPAC at $900M valuation
Nautilus Biotechnology, a Seattle-based startup, announced that it will go public via a special purpose acquisition (SPAC). Founded in 2016, Nautilus is building a combination
Just-Evotec Biologics expands COVID-19 contract with DOD
Just-Evotec Biologics announced a $28.6 million agreement with the Department of Defense to manufacture monoclonal antibodies for use against the COVID-19 virus. The antibody treatment
Bristol Myers Squibb’s CAR-T liso-cel wins long-delayed FDA nod
Bristol Myers Squibb gained FDA approval for its CAR-T drug liso-cel, which will be called Breyanzi. The drug will be available for patients with certain
With $588M IPO, Sana leads wave of new biotechs going public
Seattle’s Sana Biotechnology raised $588 million in its stock market debut, showcasing investors’ continued interest in the life science industry after a record-setting 2020. The
Seattle life science funding expected to be big in 2021
Washington’s life science sector is looking to build upon 2020’s record funding as the industry continues to provide critical research and treatments to combat the